According to a study published on Thursday, a double dosage of the COVID-19 vaccine is most likely to reduce by half the chance of long-term COVID-19 effects in adults who receive it.
According to research undertaken by a team from King’s College London, patients who have been double-jabbed are 73 percent less likely to be admitted to a hospital, and the severity of their symptoms is lowered by about a third.
“We discovered that receiving two vaccine doses reduced the likelihood of experiencing symptoms for at least 28 days following a post-vaccination infection by nearly half,” according to the study, which was published in a scientific publication.
The findings show that those who have received double vaccination are at lower risk of long-term COVID infection when taking into account the already known lower risk of infection overall.
The researchers examined data from more than 2 million participants who used the COVID Symptom Study app in the United Kingdom to register their symptoms, tests, and vaccination status between December 2017 and July 2018.
A total of 6,030 of them tested positive for the virus after at least two weeks of receiving their first dose, whereas just 2,370 individuals tested positive for the virus within at least one week of receiving their second injection.
According to the findings of the study, people who were fully vaccinated experienced milder and less frequent symptoms of the virus than those who were not vaccinated.
Additional research found that persons over the age of 60 who had been double-jabbed were more likely than others to have no symptoms, demonstrating that the jabs are effective in preventing those who are elderly or prone to disease.
Do you have something to say to the story? Please share it in the comments section below.